CSF2 and neoplasm: T-VEC harbors two copies of the human granulocyte-macrophage colony-stimulating factor (GM-CSF) gene, inserted into the ICP34.5/ICP47-deleted version of strain JS1, which may further enhance the virus-induced systemic anti-tumor immune response [21].